Tuesday
Jan172017

GREAT NEWS FROM THE DOROTHY FOUNDATION AND OUR PARTNERSHIP WITH CANCER COMMONS.

January 2017 -  cancercommons.org

 

The Dorothy Foundation continues to partner with the innovative work at Cancer Commons with the goal of providing more treatment options for current cancer patients. Marty Tenenbaum and Dr. Emma Shtivelman have utilized one of the most innovative information based patient oriented programs to assist patients and their oncologists in the fight against cancer. We urge everyone battling cancer to get the word out on the data sharing that is changing the way we treat cancer through the remarkable work at Cancer Commons. The following letter is one of the most recent success stories. Mary Beth Zolik Smith was one of the most popular radio and news personalities in Ohio (I worked with her during the 1980's). She has quite a story to tell in her fight against Non Hodgkins Lymphoma.  We urge all of you to donate, support and get behind the great work at Cancer Commons just one of the very important partners to the Dorothy Foundation. Please take a minute and review the following letter. 

 

I can not thank you enough for your assist via the Dorothy Foundation in linking me with Cancer Commons. When I reached out to Cancer Commons I was introduced to Emma Shtivelman, Ph D. Emma was one of the most positive, knowledgeable and encouraging persons I have encountered in my long journey to combat NHL. My cancer treatments covered the usual and customary standard of care from chemotherapy to stem cell transfer. None of these interventions worked. My pursuit of information and direction relative to immune therapy and clinical trials  led me to you and your referral to Cancer Commons and Dr. Emma. You were truly the life line I had hoped for. Dr Emma helped me identify several clinical trials that were recruiting clients with refractory NHL. With Emma's resourcefulness I was linked with hospitals in Boston, Tampa, Detroit and Cleveland. I was accepted into the KITE Clinical trial at the Cleveland Clinic in late November of 2016. I had my re-engineered Tcells infused into my system on December 27, 2016 and learned on January 23, 2017 after my most recent PET scan that I had a complete response to the immune therapy. Needless to say,  my family and I are ecstatic with this news and I thank you from the bottom of my heart for your assist in this miracle. Your referral to Cancer Commons was a blessing for which I will always be grateful. If I can in any way help you help others as they navigate their cancer treatment options, please don't hesitate to call me.

Sincerely and with tremendous appreciation,

Mary Beth Zolik-Smith

PrintView Printer Friendly Version

EmailEmail Article to Friend

References (24)

References allow you to track sources for this article, as well as articles that were written in response to this article.

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

PostPost a New Comment

Enter your information below to add a new comment.

My response is on my own website »
Author Email (optional):
Author URL (optional):
Post:
 
Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>
Main | Super Patient: Diane Milne Gives Other Cancer Patients the Tools that Helped Her Survive »